GlassScriptPhysician profile
Hasan Garan
NPI 1033227319
$1,500.65
in general payments reported to CMS, 2019-2025
12 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $31.04 · 2021: $161 · 2022: $37.01 · 2023: $196 · 2024: $556 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $843 · Grant: $58.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $842.87 |
| Grant | $58.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $374.29 | 2019-2021 | |
| Abbott Laboratories | $323.18 | 2023-2025 | Aveir, Gallant, Amplatzer Amulet |
| Biotronik INC. | $242.46 | 2023-2024 | Acticor 7 Vr-T Dx, Amvia Edge, Pamira |
| Medtronic Vascular, INC. | $126.25 | 2019 | |
| Boston Scientific Corporation | $88.96 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $77.61 | 2022-2025 | Camzyos, Eliquis |
| Pfizer INC. | $59.60 | 2023-2025 | |
| Medtronic, INC. | $55.53 | 2021-2024 | Cobalt Dr Mri Surescan |
| Sanofi-Aventis U.S. LLC | $50.79 | 2021-2024 | |
| Impulse Dynamics (USA) INC. | $41.36 | 2023 | Optimizer |
| Janssen Pharmaceuticals, INC | $34.84 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $25.78 | 2025 | Wainua |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hasan Garan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.